Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Clearside Biomedi (NQ: CLSD )

1.070 UNCHANGED
Streaming Delayed Price Updated: 2:24 PM EDT, May 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 117,521
Open 1.070
Bid (Size) 1.060 (21)
Ask (Size) 1.070 (3)
Prev. Close 1.070
Today's Range 1.060 - 1.100
52wk Range 0.9000 - 1.855
Shares Outstanding 61,666,130
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga
What 8 Analyst Ratings Have To Say About Clearside Biomedical
 
Via Benzinga

Performance

YTD
-11.93%
-11.93%
1 Month
+7.00%
+7.00%
3 Month
-12.30%
-12.30%
6 Month
-3.60%
-3.60%
1 Year
-17.69%
-17.69%

More News

Read More
Clearside Biomedical: Q1 Earnings Insights
Via Benzinga
What 6 Analyst Ratings Have To Say About Clearside Biomedical
Via Benzinga
Where Clearside Biomedical Stands With Analysts
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
What 5 Analyst Ratings Have To Say About Clearside Biomedical
Via Benzinga
A Preview Of Clearside Biomedical's Earnings
Via Benzinga
Analyst Expectations for Clearside Biomedical's Future
Via Benzinga
United Airlines To Rally Around 54%? Here Are 10 Other Analyst Forecasts For Friday
Via Benzinga
Clearside Biomedical Touts Encouraging Durable Data From Investigational Candidate For Vision Disorder
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Analyst Bumps Up Clearside Biomedical Target Price After Encouraging Trial Data
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
AiViva Reports That Their Promising New Treatment For Wet AMD Is Soon To Be Ready For Clinical Trials
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2022
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful
Via Benzinga
Recap: Clearside Biomedical Q2 Earnings
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Recap Of Tuesday's Biotech Catalysts - End of The Day Summary
Via Benzinga
Clearside Biomedical Sees Initial-Stage Chronic Eye Disorder Study Results In Q4 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.